Lineage Cell Therapeutics: Q4 Earnings Insights

Lineage Cell Therapeutics LCTX reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Lineage Cell Therapeutics missed estimated earnings by 240.0%, reporting an EPS of $-0.17 versus an estimate of $-0.05.

Revenue was up $845.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.24% increase in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

LCTX Logo
LCTXLineage Cell Therapeutics Inc
Not Available-%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
34.28
Growth
Not Available
Quality
Not Available
Value
26.98
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...